vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Golden Matrix Group, Inc. (GMGI). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $49.6M, roughly 1.3× Golden Matrix Group, Inc.). Cytek Biosciences, Inc. runs the higher net margin — -70.9% vs -179.0%, a 108.0% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs -15.8%). Golden Matrix Group, Inc. produced more free cash flow last quarter ($6.4M vs $-1.8M). Over the past eight quarters, Golden Matrix Group, Inc.'s revenue compounded faster (104.6% CAGR vs 17.7%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Golden Matrix Group Inc. is a global gaming tech firm that develops and licenses proprietary online gaming platforms, social casino products and interactive solutions. It serves B2B gaming operator clients across North America, Europe and Asia-Pacific, plus runs direct-to-consumer casual gaming properties.
CTKB vs GMGI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $49.6M |
| Net Profit | $-44.1M | $-88.7M |
| Gross Margin | 52.9% | 57.5% |
| Operating Margin | -9.0% | -188.3% |
| Net Margin | -70.9% | -179.0% |
| Revenue YoY | 8.1% | -15.8% |
| Net Profit YoY | -557.1% | -4880.1% |
| EPS (diluted) | — | $-7.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $49.6M | ||
| Q3 25 | $52.3M | $47.3M | ||
| Q2 25 | $45.6M | $43.2M | ||
| Q1 25 | $41.5M | $42.7M | ||
| Q4 24 | $57.5M | $58.9M | ||
| Q3 24 | $51.5M | $41.0M | ||
| Q2 24 | $46.6M | $39.4M | ||
| Q1 24 | $44.9M | $11.8M |
| Q4 25 | $-44.1M | $-88.7M | ||
| Q3 25 | $-5.5M | $566.0K | ||
| Q2 25 | $-5.6M | $-3.6M | ||
| Q1 25 | $-11.4M | $-231.6K | ||
| Q4 24 | $9.6M | $1.9M | ||
| Q3 24 | $941.0K | $-3.4M | ||
| Q2 24 | $-10.4M | $64.9K | ||
| Q1 24 | $-6.2M | $74.5K |
| Q4 25 | 52.9% | 57.5% | ||
| Q3 25 | 52.7% | 55.8% | ||
| Q2 25 | 52.3% | 56.4% | ||
| Q1 25 | 48.6% | 56.6% | ||
| Q4 24 | 58.5% | 69.8% | ||
| Q3 24 | 56.3% | 54.7% | ||
| Q2 24 | 54.6% | 55.0% | ||
| Q1 24 | 51.3% | 28.5% |
| Q4 25 | -9.0% | -188.3% | ||
| Q3 25 | -17.6% | -0.8% | ||
| Q2 25 | -23.3% | -5.3% | ||
| Q1 25 | -36.1% | -0.2% | ||
| Q4 24 | 5.2% | 5.6% | ||
| Q3 24 | -8.2% | -2.4% | ||
| Q2 24 | -18.3% | 0.3% | ||
| Q1 24 | -23.9% | 2.4% |
| Q4 25 | -70.9% | -179.0% | ||
| Q3 25 | -10.5% | 1.2% | ||
| Q2 25 | -12.2% | -8.3% | ||
| Q1 25 | -27.5% | -0.5% | ||
| Q4 24 | 16.8% | 3.2% | ||
| Q3 24 | 1.8% | -8.3% | ||
| Q2 24 | -22.4% | 0.2% | ||
| Q1 24 | -13.8% | 0.6% |
| Q4 25 | — | $-7.73 | ||
| Q3 25 | — | $0.00 | ||
| Q2 25 | — | $-0.03 | ||
| Q1 25 | — | $0.00 | ||
| Q4 24 | — | $-0.13 | ||
| Q3 24 | — | $-0.03 | ||
| Q2 24 | — | $0.00 | ||
| Q1 24 | — | $0.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $46.5M |
| Total Assets | $461.5M | $118.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | — | ||
| Q3 25 | $93.3M | — | ||
| Q2 25 | $75.5M | — | ||
| Q1 25 | $95.3M | — | ||
| Q4 24 | $98.7M | — | ||
| Q3 24 | $162.3M | — | ||
| Q2 24 | $177.9M | — | ||
| Q1 24 | $168.8M | — |
| Q4 25 | $341.7M | $46.5M | ||
| Q3 25 | $378.6M | $123.5M | ||
| Q2 25 | $377.6M | $121.3M | ||
| Q1 25 | $379.6M | $108.5M | ||
| Q4 24 | $395.7M | $105.1M | ||
| Q3 24 | $385.5M | $94.3M | ||
| Q2 24 | $389.1M | $90.4M | ||
| Q1 24 | $392.6M | $32.1M |
| Q4 25 | $461.5M | $118.1M | ||
| Q3 25 | $494.9M | $209.8M | ||
| Q2 25 | $493.3M | $210.3M | ||
| Q1 25 | $482.6M | $214.0M | ||
| Q4 24 | $499.5M | $213.7M | ||
| Q3 24 | $491.2M | $213.5M | ||
| Q2 24 | $483.7M | $191.5M | ||
| Q1 24 | $492.1M | $37.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $8.2M |
| Free Cash FlowOCF − Capex | $-1.8M | $6.4M |
| FCF MarginFCF / Revenue | -2.9% | 13.0% |
| Capex IntensityCapex / Revenue | 1.6% | 3.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $19.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $8.2M | ||
| Q3 25 | $-3.9M | $7.0M | ||
| Q2 25 | $108.0K | $2.4M | ||
| Q1 25 | $-125.0K | $7.7M | ||
| Q4 24 | $2.0M | — | ||
| Q3 24 | $13.2M | $4.8M | ||
| Q2 24 | $6.2M | — | ||
| Q1 24 | $4.0M | $8.2K |
| Q4 25 | $-1.8M | $6.4M | ||
| Q3 25 | $-4.6M | $6.2M | ||
| Q2 25 | $-1.5M | $-89.4K | ||
| Q1 25 | $-974.0K | $6.6M | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $12.2M | $2.3M | ||
| Q2 24 | $5.2M | — | ||
| Q1 24 | $3.4M | $6.7K |
| Q4 25 | -2.9% | 13.0% | ||
| Q3 25 | -8.7% | 13.1% | ||
| Q2 25 | -3.2% | -0.2% | ||
| Q1 25 | -2.3% | 15.5% | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 23.7% | 5.6% | ||
| Q2 24 | 11.0% | — | ||
| Q1 24 | 7.6% | 0.1% |
| Q4 25 | 1.6% | 3.6% | ||
| Q3 25 | 1.3% | 1.8% | ||
| Q2 25 | 3.5% | 5.7% | ||
| Q1 25 | 2.0% | 2.6% | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 2.0% | 6.0% | ||
| Q2 24 | 2.3% | — | ||
| Q1 24 | 1.3% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 12.42× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.11× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
GMGI
| R Kings And CFAC | $43.8M | 88% |
| Other | $5.8M | 12% |
